Pierre‐Yves Robert

Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis

Stefano Bonini, Alessandro Lambìase, Paolo Rama et al. · Ophthalmology · 2018 · 251 citations · Full text

Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients

É. Liozon, François R. Herrmann, K.H. Ly et al. · The American Journal of Medicine · 2001 · 226 citations

Visual Loss, Vascular Disease, Ocular Disease +9

Intracameral cefuroxime injection at the end of cataract surgery to reduce the incidence of endophthalmitis: French study

G. Barreau, M Mounier, Benôıt Marin et al. · Journal of Cataract & Refractive Surgery · 2012 · 106 citations

Phase I Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis

Stefano Bonini, Alessandro Lambìase, Paolo Rama et al. · Ophthalmology · 2018 · 75 citations · Full text

Efficacy and Safety of a Cationic Emulsion in the Treatment of Moderate to Severe Dry Eye Disease: A Randomized Controlled Study

Pierre‐Yves Robert, Béatrice Cochener, Mourad Amrane et al. · European Journal of Ophthalmology · 2016 · 46 citations · Full text